Glaucoma Australia is thrilled to welcome Senior Orthoptist Patient Educator Val Tosswill to provide comprehensive support to patients enrolled in its SiGHTWiSE Patient Support Program.
The landmark Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial – that ultimately recommended selective laser trabeculoplasty (SLT) as a first-line glaucoma intervention – has published six-year results further demonstrating the clinical effectiveness of the treatment.
To accommodate an ageing population, glaucoma management is transitioning from reactive treatment regimens to proactive ones. Three key experts detail what this mindset shift entails and how they employ it in practise.
As issues with compliance and a reduction of life-quality are commonly associated with eye drops, the industry is exploring new avenues that are revolutionising the treatment landscape.
With the rising numbers of patients diagnosed with glaucoma – and oversubscription of public ophthalmology departments – the Glaucoma Community Collaborative Care Program at the Royal Victorian Eye and Ear Hospital in Melbourne is designed to alleviate some of this pressure.
Award winning journalist and Seven News Melbourne newsreader, Mike Amor has joined Glaucoma Australia as an official Ambassador in the fight against eye disease and just in time for World Glaucoma Week (10-16 March).
This World Glaucoma Week (10–16 March 2024), Glaucoma Australia is urging all Australians to have their eyes checked, as well as reminding those with a glaucoma diagnosis to adhere to their treatment to slow its progression and save precious sight.
Just over a year ago, a glaucoma specialist told Duncan Craib he was “five minutes from midnight”: unless urgent action was taken, he’d likely be blind in two to three months.
When Bette Smith’s cousin told her they had glaucoma in the family, she did what all Australians should be doing, she got her eyes checked.